| To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. (NCT04702542) | Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan | 2022-04-30 |
| Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer (NCT05010954) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2021-10-18 |
| A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer (NCT05208268) | Eisai Korea Inc. | 2020-07-23 |
| A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer (NCT03553563) | AstraZeneca | 2018-07-24 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection (NCT03050359) | Takeda | 2017-04-05 |
| A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA (NCT03057171) | Yonsei University | 2015-05-01 |
| Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin (NCT02423187) | Eisai Co., Ltd. | 2015-03-17 |
| BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects (NCT01964131) | AstraZeneca | 2013-10-01 |
| Nexium Capsules LDA Specific Clinical Experience Investigation (NCT01729182) | AstraZeneca | 2013-01-01 |
| Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation (NCT01562600) | AstraZeneca | 2012-04-19 |
| A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy (NCT01568385) | Takeda | 2012-04-01 |
| Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer (NCT01452724) | Takeda | 2011-10-01 |
| Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation (NCT01435525) | AstraZeneca | 2011-09-01 |
| Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers (NCT01199536) | AstraZeneca | 2010-11-01 |
| Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets (NCT01037491) | Taipei Veterans General Hospital, Taiwan | 2009-10-01 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (NCT02847455) | Livzon Pharmaceutical Group Inc. | 2008-08-01 |
| Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID (NCT00542789) | AstraZeneca | 2007-08-01 |
| A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers (NCT00762359) | Takeda | 2007-05-01 |
| Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs (NCT00787254) | Takeda | 2007-04-01 |
| Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (NCT00441727) | AstraZeneca | 2007-02-01 |
| Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers (NCT00284908) | STEBA France | 2006-09-01 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) (NCT00952978) | Livzon Pharmaceutical Group Inc. | 2005-09-01 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) (NCT00953381) | Livzon Pharmaceutical Group Inc. | 2004-10-01 |
| MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) (NCT00543868) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection (NCT00197418) | Hamamatsu University | 2003-08-01 |
| Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori (NCT00149084) | Hamamatsu University | 2003-04-01 |
| Helicobacter Pylori Eradication With a New Sequential Treatment (NCT00132171) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2001-01-01 |
| Lymphocytic Subsets and Cytokine Production With H. Pylori Infection (NCT00173953) | National Taiwan University Hospital | 2001-01-01 |
| Cytokine Gene Polymorphisms in Gastric Diseases (NCT00197470) | Hamamatsu University | 2000-01-01 |
| Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection (NCT00854451) | National Taiwan University Hospital | 1996-08-01 |